April Meyer

Title(s)Staff Res Assoc , Chemistry and Biochemistry
SchoolVc-academic Affairs
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability. Oncotarget. 2023 02 11; 14:133-145. Wang CG, Peiris MN, Meyer AN, Nelson KN, Donoghue DJ. PMID: 36780330; PMCID: PMC9924825.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk. Cytokine Growth Factor Rev. 2022 12; 68:93-106. Aepala MR, Peiris MN, Jiang Z, Yang W, Meyer AN, Donoghue DJ. PMID: 36153202.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Proteomic analysis reveals dual requirement for Grb2 and PLC?1 interactions for BCR-FGFR1-Driven 8p11 cell proliferation. Oncotarget. 2022; 13:659-676. Peiris MN, Meyer AN, Warda D, Campos AR, Donoghue DJ. PMID: 35574218; PMCID: PMC9093983.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    4. Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment. Oncotarget. 2021 Jan 05; 12(1):22-36. Ko J, Meyer AN, Haas M, Donoghue DJ. PMID: 33456711; PMCID: PMC7800776.
      View in: PubMed   Mentions: 3     Fields:    
    5. Typical achondroplasia secondary to a unique insertional variant of FGFR3 with in vitro demonstration of its effect on FGFR3 function. Am J Med Genet A. 2021 03; 185(3):798-805. Meyer AN, Modaff P, Wang CG, Wohler E, Sobreira NL, Donoghue DJ, Pauli RM. PMID: 33368972; PMCID: PMC8083996.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    6. Oncogenic fusion protein FGFR2-PPHLN1: Requirements for biological activation, and efficacy of inhibitors. Transl Oncol. 2020 Dec; 13(12):100853. Li F, Meyer AN, Peiris MN, Nelson KN, Donoghue DJ. PMID: 32854034; PMCID: PMC7451725.
      View in: PubMed   Mentions: 3  
    7. Characterization of iPS87, a prostate cancer stem cell-like cell line. Oncotarget. 2020 Mar 24; 11(12):1075-1084. Assoun EN, Meyer AN, Jiang MY, Baird SM, Haas M, Donoghue DJ. PMID: 32256979; PMCID: PMC7105161.
      View in: PubMed   Mentions: 4     Fields:    
    8. Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation. Haematologica. 2020 05; 105(5):1262-1273. Peiris MN, Meyer AN, Nelson KN, Bisom-Rapp EW, Donoghue DJ. PMID: 31439673; PMCID: PMC7193502.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    9. Oncogenic mutations in IKK� function through global changes induced by K63-linked ubiquitination and result in autocrine stimulation. PLoS One. 2018; 13(10):e0206014. Meyer AN, Gallo LH, Ko J, Cardenas G, Nelson KN, Siari A, Campos AR, Whisenant TC, Donoghue DJ. PMID: 30335863; PMCID: PMC6193727.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Oncogenic driver FGFR3-TACC3 is dependent on membrane trafficking and ERK signaling. Oncotarget. 2018 Sep 28; 9(76):34306-34319. Nelson KN, Meyer AN, Wang CG, Donoghue DJ. PMID: 30344944; PMCID: PMC6188140.
      View in: PubMed   Mentions: 13     Fields:    
    11. Receptor Tyrosine Kinases: Translocation Partners in Hematopoietic Disorders. Trends Mol Med. 2017 01; 23(1):59-79. Nelson KN, Peiris MN, Meyer AN, Siari A, Donoghue DJ. PMID: 27988109.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    12. Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation. Mol Cancer Res. 2016 05; 14(5):458-69. Nelson KN, Meyer AN, Siari A, Campos AR, Motamedchaboki K, Donoghue DJ. PMID: 26869289.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    13. Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations. Cytokine Growth Factor Rev. 2015 Aug; 26(4):425-49. Gallo LH, Nelson KN, Meyer AN, Donoghue DJ. PMID: 26003532.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    14. Fibroblast growth factor receptor 3 interacts with and activates TGF�-activated kinase 1 tyrosine phosphorylation and NF?B signaling in multiple myeloma and bladder cancer. PLoS One. 2014; 9(1):e86470. Salazar L, Kashiwada T, Krejci P, Meyer AN, Casale M, Hallowell M, Wilcox WR, Donoghue DJ, Thompson LM. PMID: 24466111; PMCID: PMC3900522.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    15. Novel Lys63-linked ubiquitination of IKK� induces STAT3 signaling. Cell Cycle. 2014; 13(24):3964-76. Gallo LH, Meyer AN, Motamedchaboki K, Nelson KN, Haas M, Donoghue DJ. PMID: 25486864; PMCID: PMC4615003.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    16. Tyrosine phosphorylation allows integration of multiple signaling inputs by IKK�. PLoS One. 2013; 8(12):e84497. Meyer AN, Drafahl KA, McAndrew CW, Gilda JE, Gallo LH, Haas M, Brill LM, Donoghue DJ. PMID: 24386391; PMCID: PMC3873999.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    17. Suppression of severe achondroplasia with developmental delay and acanthosis nigricans by the p.Thr651Pro mutation. Am J Med Genet A. 2014 Jan; 164A(1):243-50. Manickam K, Donoghue DJ, Meyer AN, Snyder PJ, Prior TW. PMID: 24352917.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    18. Early human prostate adenocarcinomas harbor androgen-independent cancer cells. PLoS One. 2013; 8(9):e74438. Fi?ones RR, Yeargin J, Lee M, Kaur AP, Cheng C, Sun P, Wu C, Nguyen C, Wang-Rodriguez J, Meyer AN, Baird SM, Donoghue DJ, Haas M. PMID: 24086346; PMCID: PMC3783414.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    19. The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling. PLoS One. 2010 Dec 22; 5(12):e14412. Drafahl KA, McAndrew CW, Meyer AN, Haas M, Donoghue DJ. PMID: 21203561; PMCID: PMC3008709.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    20. Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells. Cancer Res. 2008 Sep 15; 68(18):7362-70. Meyer AN, McAndrew CW, Donoghue DJ. PMID: 18794123; PMCID: PMC2745924.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    21. Spy1 enhances phosphorylation and degradation of the cell cycle inhibitor p27. Cell Cycle. 2007 Aug 01; 6(15):1937-45. McAndrew CW, Gastwirt RF, Meyer AN, Porter LA, Donoghue DJ. PMID: 17671428.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    22. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. J Biol Chem. 2004 Jul 02; 279(27):28450-7. Meyer AN, Gastwirt RF, Schlaepfer DD, Donoghue DJ. PMID: 15105428.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    23. Initial activation of cyclin-B1-cdc2 kinase requires phosphorylation of cyclin B1. EMBO Rep. 2002 Jun; 3(6):551-6. Peter M, Le Peuch C, Labbé JC, Meyer AN, Donoghue DJ, Dorée M. PMID: 12034754; PMCID: PMC1084145.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    April's Networks
    Concepts (161)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (6)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California